Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CHF | 0.00% | -10.03% | +70.73% |
May. 01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
Apr. 17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.73% | 5.18M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.88% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+4.49% | 8.82B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Polyphor Appoints Debra Barker as Chief Medical and Development Officer, Effective May 01, 2017